HIRAS to revise economic effectiveness guideline for medicines
Published: 2010-04-22 07:00:00
Updated: 2010-04-22 07:00:00
The Health Insurance Review Assessment and Service said on April 19 that it is considering modifying the economic effectiveness guideline for medicines by reflecting the recent scientific outcomes and local research situations of pharmaceutical firms.
In a recent working-level gathering with p...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
